ATE338135T1 - Induziertes genexpressionssystem basierend auf ecdysonrezeptoren - Google Patents

Induziertes genexpressionssystem basierend auf ecdysonrezeptoren

Info

Publication number
ATE338135T1
ATE338135T1 AT01922524T AT01922524T ATE338135T1 AT E338135 T1 ATE338135 T1 AT E338135T1 AT 01922524 T AT01922524 T AT 01922524T AT 01922524 T AT01922524 T AT 01922524T AT E338135 T1 ATE338135 T1 AT E338135T1
Authority
AT
Austria
Prior art keywords
ecdyson
receptors
gene expression
system based
expression system
Prior art date
Application number
AT01922524T
Other languages
English (en)
Inventor
Subba Reddy Palli
Marianna Zinovjevna Kapitskaya
Dean Ervin Cress
Original Assignee
Rheogene Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rheogene Holdings Inc filed Critical Rheogene Holdings Inc
Application granted granted Critical
Publication of ATE338135T1 publication Critical patent/ATE338135T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01922524T 2000-03-22 2001-03-21 Induziertes genexpressionssystem basierend auf ecdysonrezeptoren ATE338135T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19135500P 2000-03-22 2000-03-22
US26979901P 2001-02-20 2001-02-20

Publications (1)

Publication Number Publication Date
ATE338135T1 true ATE338135T1 (de) 2006-09-15

Family

ID=26886975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01922524T ATE338135T1 (de) 2000-03-22 2001-03-21 Induziertes genexpressionssystem basierend auf ecdysonrezeptoren

Country Status (11)

Country Link
US (1) US7091038B2 (de)
EP (1) EP1266015B1 (de)
JP (1) JP5031967B2 (de)
CN (1) CN1304578C (de)
AR (1) AR028276A1 (de)
AT (1) ATE338135T1 (de)
AU (2) AU2001249315A1 (de)
CA (1) CA2404253C (de)
DE (1) DE60122685T2 (de)
MX (1) MXPA02009157A (de)
WO (1) WO2001070816A2 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033600A1 (en) 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
US8105825B2 (en) * 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
EP1356066A2 (de) * 2000-10-24 2003-10-29 Syngenta Participations AG Kontrolle der pflanzengenexpression
EP1373470B1 (de) 2001-02-20 2013-04-24 Intrexon Corporation Neue substitutionsmutantenrezeptoren und ihre verwendung in einem induzierbaren genexpressionssystem auf basis eines nukleären rezeptors
JP4955904B2 (ja) 2001-02-20 2012-06-20 イントレキソン コーポレーション 新規エクジソン受容体／無脊椎動物レチノイドｘ受容体−ベースの誘導性遺伝子発現システム
WO2002066614A2 (en) * 2001-02-20 2002-08-29 Rheogene Holdings, Inc. Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
EP1534738B1 (de) 2001-02-20 2012-06-20 Intrexon Corporation Neue substitutionsmutantenrezeptoren und ihre verwendung in einem induzierbaren genexpressionsystem auf grundlage eines nukleären rezeptors
DE10244149A1 (de) * 2001-09-25 2003-04-30 Werner Keber Verfahren und Einrichtung zum Verhindern einer unzulässigen Flugannäherung von Flugzeugen an zu schützende Bodenobjeke
MXPA04002810A (es) 2001-09-26 2005-06-06 Rheogene Holdings Inc Acidos nucleicos receptores de ecdisona de saltarilla, polipeptidos, y sus usos.
US7919269B2 (en) 2001-09-26 2011-04-05 Intrexon Corporation Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
WO2003066676A1 (en) * 2002-02-05 2003-08-14 Geymonat S.P.A. Production process of recombinant placental growth factor
US9154906B2 (en) 2002-03-28 2015-10-06 Telecommunication Systems, Inc. Area watcher for wireless network
US7375093B2 (en) * 2002-07-05 2008-05-20 Intrexon Corporation Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7422863B2 (en) 2003-02-07 2008-09-09 Kumiai Chemical Industry Co., Ltd. Molting hormone receptor and method for screening ligand to the receptor
US7304161B2 (en) 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
AU2011202682B2 (en) * 2003-02-10 2013-11-28 Intrexon Corporation Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7456315B2 (en) 2003-02-28 2008-11-25 Intrexon Corporation Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US8637237B2 (en) 2003-08-29 2014-01-28 The University Of North Carolina At Greensboro Methods, compositions, and systems for the identification of species-specific or developmental stage-specific insecticides
WO2005022167A2 (en) * 2003-08-29 2005-03-10 The University Of North Carolina At Greensboro Compounds that act to modulate insect growth and methods and systems for identifying such compounds
US20050164210A1 (en) * 2004-01-23 2005-07-28 Vivek Mittal Regulated polymerase III expression systems and related methods
US7935510B2 (en) * 2004-04-30 2011-05-03 Intrexon Corporation Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
JP4517347B2 (ja) * 2004-07-02 2010-08-04 国立大学法人北海道大学 植物を用いたエストロゲン様物質の検出方法
US8097431B2 (en) * 2004-08-04 2012-01-17 University Of Utah Research Foundation Methods and compositions for detecting steroids
US8115059B1 (en) 2005-07-22 2012-02-14 University Of Kentucky Research Foundation Gene expression modulation system for use in plants and method for modulating gene expression in plants
JP2009505955A (ja) 2005-07-22 2009-02-12 アムゲン インコーポレイティッド アニリンスルホンアミド誘導体およびそれらの使用
EP2043662B1 (de) 2006-07-26 2015-09-09 Intrexon Corporation Verfahren und zusammensetzungen zur behandlung von krankheiten
CN101016518B (zh) * 2006-09-12 2010-07-28 南方医科大学 一种生物杀虫剂筛选模型及其制备方法和应用
WO2008137681A2 (en) * 2007-05-02 2008-11-13 Intrexon Corporation Pp1 ligands
CA2689137C (en) 2007-05-29 2017-05-02 Intrexon Corporation Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
CA2698212A1 (en) 2007-08-23 2009-02-26 Intrexon Corporation Methods and compositions for diagnosing disease
JP2010538647A (ja) * 2007-09-17 2010-12-16 ローム アンド ハース カンパニー 植物における生理的応答を改変するための組成物および方法
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
BRPI0818287A2 (pt) 2007-10-08 2015-11-03 Intrexon Corp células dendríticas manipuladas e usos para o tratamento do câncer.
EP2265116A4 (de) * 2008-03-14 2013-02-06 Intrexon Corp Steroid-liganden und ihre verwendung bei der gene-switch-modulation
RU2573912C2 (ru) 2008-10-08 2016-01-27 Интрексон Корпорейшн Сконструированные клетки, экспрессирующие множественные иммуномодуляторы, и их применения
CA2752697A1 (en) 2009-03-05 2010-09-10 Rohm And Haas Company Control of targeted turnover of key ethylene hormone signaling pathway proteins to modulate ethylene sensitivity in plants
KR20130010121A (ko) 2010-03-23 2013-01-25 인트렉손 코포레이션 치료적 단백질을 조건부로 발현하는 벡터，상기 벡터를 포함하는 숙주 세포 및 이의 용도
CA2811297C (en) 2010-09-26 2016-10-25 Donald O'keefe Method of recombinant macromolecular production
JP6189754B2 (ja) 2011-03-04 2017-08-30 イントレキソン コーポレーション タンパク質を条件的に発現するベクター
WO2012145572A1 (en) 2011-04-20 2012-10-26 The Trustees Of The University Of Pennsylvania Regimens and compositions for aav-mediated passive immunization of airborne pathogens
US9127024B2 (en) 2013-03-15 2015-09-08 Intrexon Corporation Boron-containing diacylhydrazines
WO2015012924A2 (en) 2013-04-29 2015-01-29 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof
WO2015009760A1 (en) 2013-07-15 2015-01-22 Donald Danforth Plant Science Center Enhanced oil production and stress tolerance in plants
CN103555727B (zh) * 2013-10-14 2015-06-10 中国水产科学研究院淡水渔业研究中心 一种中华绒螯蟹性早熟个体活体分子检测方法
AU2015317862A1 (en) 2014-09-17 2017-04-06 Intrexon Corporation Boron-containing diacylhydrazine compounds
WO2016160791A1 (en) * 2015-03-30 2016-10-06 Intrexon Corporation Ligand inducible polypeptide coupler system
EA201792500A1 (ru) 2015-05-13 2018-04-30 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Aav-опосредованная экспрессия антител против гриппа и способы их использования
WO2017062953A1 (en) 2015-10-10 2017-04-13 Intrexon Corporation Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
SG11201803934YA (en) 2015-11-11 2018-06-28 Intrexon Corp Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
ES2970865T3 (es) 2015-12-16 2024-05-31 Gritstone Bio Inc Identificación, fabricación y uso de neoantígenos
CA3025667A1 (en) 2016-06-08 2017-12-14 Intrexon Corporation Cd33 specific chimeric antigen receptors
UY37343A (es) 2016-07-25 2018-02-28 Intrexon Corp Control del fenotipo en plantas
WO2018089527A1 (en) 2016-11-09 2018-05-17 Intrexon Corporation Frataxin expression constructs
CN106589125B (zh) * 2016-12-23 2020-04-14 江苏省农业科学院 抗绿盲蝽蜕皮激素受体蛋白的单克隆抗体及其用途
EP3568474A1 (de) 2017-01-10 2019-11-20 Intrexon Corporation Modulation der expression von polypeptiden über neue genschalterexpressionssysteme
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
PT3589730T (pt) 2017-02-28 2024-02-28 Univ Pennsylvania Vetor de vírus adenoassociado (aav) de clado f e suas utilizações
UY37620A (es) 2017-02-28 2018-08-31 Univ Pennsylvania Vacunas contra la gripe mediadas por aav novedosas
CA3065930A1 (en) 2017-06-07 2018-12-13 Intrexon Corporation Expression of novel cell tags
EP4576103A3 (de) 2017-10-10 2025-08-27 Gritstone bio, Inc. Neoantigenidentifizierung mit hotspots
CN111630602A (zh) 2017-11-22 2020-09-04 磨石肿瘤生物技术公司 减少新抗原的接合表位呈递
EP3759131A4 (de) 2018-02-27 2021-12-01 Gritstone bio, Inc. Neoantigen-identifizierung mit pan-allelmodellen
KR20250136930A (ko) 2018-03-06 2025-09-16 프레시전 인코포레이티드 사람 파필로마바이러스 백신 및 이의 용도
IL277128B2 (en) 2018-03-06 2025-11-01 Precigen Inc Hepatitis b vaccines and uses of the same
US12460226B2 (en) 2018-04-16 2025-11-04 The Trustees Of The University Of Pennsylvania Compositions and methods for treating duchenne muscular dystrophy
CN108913732B (zh) * 2018-07-31 2022-02-08 华东理工大学 一种莫纳可林j异源生产的方法及应用
CN109810993B (zh) * 2019-03-25 2022-05-31 临沂大学 一种蝗虫β-D-葡萄糖苷水解酶基因及其应用
WO2020206056A1 (en) 2019-04-04 2020-10-08 Greenvenus Llc Peptides and methods of plant protection
CN110592095A (zh) * 2019-09-26 2019-12-20 浙江海洋大学 曼氏无针乌贼维甲酸x受体基因的克隆和表达
US20230111619A1 (en) * 2019-11-19 2023-04-13 Teknologian Tutkimuskeskus Vtt Oy Non-viral transcription activation domains and methods and uses related thereto
TW202237850A (zh) 2020-12-01 2022-10-01 賓州大學委員會 具有組織特異性靶向基序的新穎構成物及含有其之組成物
CA3216004A1 (en) 2021-04-23 2022-10-27 The Trustees Of The University Of Pennsylvania Novel compositions with brain-specific targeting motifs and compositions containing same
EP4409010A1 (de) 2021-10-02 2024-08-07 The Trustees of The University of Pennsylvania Neue aav-kapside und diese enthaltende zusammensetzungen
CN119317718A (zh) 2022-01-25 2025-01-14 宾夕法尼亚州大学信托人 用于改善心脏转导和肝脏去靶向的aav衣壳
WO2024130070A2 (en) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
EP4634394A2 (de) 2022-12-17 2025-10-22 The Trustees of The University of Pennsylvania Rekombinante aav-mutantenvektoren mit herz- und skelettmuskelspezifischen zielmotiven und zusammensetzungen damit
TW202516019A (zh) 2023-06-29 2025-04-16 賓州大學委員會 具中樞神經系統靶向模體的突變aav及含有其之組成物
WO2025102034A1 (en) 2023-11-10 2025-05-15 The Trustees Of The University Of Pennsylvania Gene therapy for barth syndrome
WO2025106661A1 (en) 2023-11-14 2025-05-22 The Trustees Of The University Of Pennsylvania Compositions with cardiac and skeletal musclespecific targeting motifs and uses thereof
CN119817530B (zh) * 2025-02-25 2025-07-15 浙江省农业科学院 一种利用孤雌生殖辅助家蚕品种选育的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
JPH11508121A (ja) 1990-03-22 1999-07-21 ザ ソーク インスティテュート フォア バイオロジカル スタディーズ 昆虫レチノイドレセプター組成物および方法
ATE293699T1 (de) * 1995-03-03 2005-05-15 Syngenta Participations Ag Kontrolle der pflanzengenexpression durch rezeptor-vermittelte transaktivation in gegenwart von einem chemischen ligand
CA2200423C (en) * 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
AU734051B2 (en) * 1996-04-05 2001-05-31 Salk Institute For Biological Studies, The Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
US5919667A (en) * 1996-06-20 1999-07-06 The Salk Institute For Biological Studies Modular assembly retroviral vectors and uses thereof
EP0998560A1 (de) * 1997-07-10 2000-05-10 The Salk Institute For Biological Studies Modifizierte lepidoptera-rezeptoren und hybride, multifunktionelle proteine zur regulation der expression von transgenen
US6300488B1 (en) 1997-07-10 2001-10-09 The Salk Institute For Biological Studies Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression
JP2003524368A (ja) * 1997-08-26 2003-08-19 アリアド ジーン セラピューティクス インコーポレイテッド ニ量化ドメイン、三量化ドメインまたは四量化ドメインおよび補足的非相同転写活性化ドメイン、転写抑制ドメイン、ｄｎａ結合ドメインまたはリガンド結合ドメインを含む融合蛋白
US6333318B1 (en) * 1998-05-14 2001-12-25 The Salk Institute For Biological Studies Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
US6258603B1 (en) * 1998-06-17 2001-07-10 Rohm And Haas Company Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

Also Published As

Publication number Publication date
JP2003527852A (ja) 2003-09-24
WO2001070816A2 (en) 2001-09-27
US7091038B2 (en) 2006-08-15
CA2404253C (en) 2014-05-13
CN1422334A (zh) 2003-06-04
DE60122685D1 (de) 2006-10-12
CA2404253A1 (en) 2001-09-27
US20020119521A1 (en) 2002-08-29
MXPA02009157A (es) 2004-04-05
AU2007200882B2 (en) 2011-05-19
WO2001070816A3 (en) 2002-08-29
EP1266015B1 (de) 2006-08-30
DE60122685T2 (de) 2007-08-23
JP5031967B2 (ja) 2012-09-26
AU2007200882A1 (en) 2007-03-22
CN1304578C (zh) 2007-03-14
AU2001249315A1 (en) 2001-10-03
EP1266015A2 (de) 2002-12-18
AR028276A1 (es) 2003-04-30

Similar Documents

Publication Publication Date Title
DE60122685D1 (de) Induziertes genexpressionssystem basierend auf ecdysonrezeptoren
DE60329919D1 (de) En auf tensidbasis
DE60031869D1 (de) Kapazitiver druckwandler
DE60044784D1 (de) Auf software basierter stempelgeber
DE60109979D1 (de) Navigationssystem
DE60123299D1 (de) Navigationssystem
DE50212862D1 (de) Emulsionen auf basis spezieller emulgatoren
DE60139338D1 (de) Bioprothetisches herzklappensystem
DE69905638D1 (de) Fussgänger-Aufprallsensorsystem
EP1497655A4 (de) Verbessertes genexpressionssystem
DE60125769D1 (de) Verbessertes elektroentionisierungssystem
EP1132713A4 (de) Positionsinformationssystem
DE50002814D1 (de) Ansaugsystem
DE60205144D1 (de) Kraftstoffsystemteil
DE50212435D1 (de) Emulsionen auf basis spezieller emulgatoren
DE60132946D1 (de) Navigationssystem
DE50114578D1 (de) Navigationssystem
FI19992495A7 (fi) Lippujärjestelmä
DE60134818D1 (de) Informationbereitstellungssystem
DE10196521T1 (de) Brennstoff-System
DE69930599D1 (de) Kraftstoffsystem
DE60036888D1 (de) Navigationssystem
DE60043435D1 (de) Navigationssystem
DE60028416D1 (de) Duplexdrucksystem
DE50104318D1 (de) Lernsystem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1266015

Country of ref document: EP

EEIH Change in the person of patent owner